Evidence map›Paper›PMID 42428230›Full record

ArticleUrology case reports2026

Pigmented microcystic chromophobe renal cell carcinoma in a patient with end-stage kidney disease: Importance of evaluating non-neoplastic renal parenchyma.

Adam Nedoroscik, Jan Gajdos, Vladimir Borovicka, Martin Kment, Marek Kollar

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Urology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Adam NedoroscikInstitute of Pathology General University Hospital in Prague, First Faculty of Medicine, Prague, Czech Republic.
Jan GajdosInstitute of Pathology General University Hospital in Prague, First Faculty of Medicine, Prague, Czech Republic.
Vladimir BorovickaTransplantation Surgery Department, Institute of Clinical and Experimental Medicine, Prague, Czech Republic.
Martin KmentThe Clinical and Transplant Pathology Centre, Institute of Clinical and Experimental Medicine, Prague, Czech Republic.
Marek KollarThe Clinical and Transplant Pathology Centre, Institute of Clinical and Experimental Medicine, Prague, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adenomatous pigmented microcystic chromophobe renal cell carcinoma (PMCRCC) is a rare variant of chromophobe renal cell carcinoma. We report a 72-year-old male with end-stage chronic kidney disease undergoing transplant evaluation, in whom PMCRCC and concomitant focal segmental glomerulosclerosis (FSGS) were identified after nephrectomy. The tumor showed characteristic microcystic architecture, focal pigmentation, and immunophenotypic features. To our knowledge, this is among the few reported cases of PMCRCC with detailed evaluation of the accompanying non-neoplastic renal parenchyma. The case highlights the characteristic features of this rare tumor variant and illustrates the value of systematic assessment of non-neoplastic kidney tissue in nephrectomy specimens.

Indexed as

Chromophobe renal cell carcinomaFocal segmental glomerulosclerosisMicrocystic variantNephrectomyRenal pathology

Identifiers

PMID42428230
PMCPMC13347934

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.